186 related articles for article (PubMed ID: 16873289)
1. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
[TBL] [Abstract][Full Text] [Related]
2. Distinct expression of Survivin splice variants in breast carcinomas.
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
[TBL] [Abstract][Full Text] [Related]
3. Lack of prognostic significance of survivin, survivin-deltaEx3, survivin-2B, galectin-3, bag-1, bax-alpha and MRP-1 mRNAs in breast cancer.
O'Driscoll L; Linehan R; M Kennedy S; Cronin D; Purcell R; Glynn S; W McDermott E; D Hill A; J O'Higgins N; Parkinson M; Clynes M
Cancer Lett; 2003 Nov; 201(2):225-36. PubMed ID: 14607338
[TBL] [Abstract][Full Text] [Related]
4. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
Végran F; Boidot R; Oudin C; Defrain C; Rebucci M; Lizard-Nacol S
Oncogene; 2007 Jan; 26(2):290-7. PubMed ID: 16847456
[TBL] [Abstract][Full Text] [Related]
5. Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer.
Ryan B; O'Donovan N; Browne B; O'Shea C; Crown J; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Br J Cancer; 2005 Jan; 92(1):120-4. PubMed ID: 15611790
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapy.
Boidot R; Vegran F; Lizard-Nacol S
Int J Mol Med; 2009 Feb; 23(2):285-91. PubMed ID: 19148555
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.
Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M
Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
[TBL] [Abstract][Full Text] [Related]
9. Survivin expression predicts early recurrence in early-stage breast cancer.
Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
[TBL] [Abstract][Full Text] [Related]
10. In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemia.
Wagner M; Schmelz K; Wuchter C; Ludwig WD; Dörken B; Tamm I
Int J Cancer; 2006 Sep; 119(6):1291-7. PubMed ID: 16619249
[TBL] [Abstract][Full Text] [Related]
11. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
12. The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.
Knauer SK; Bier C; Schlag P; Fritzmann J; Dietmaier W; Rödel F; Klein-Hitpass L; Kovács AF; Döring C; Hansmann ML; Hofmann WK; Kunkel M; Brochhausen C; Engels K; Lippert BM; Mann W; Stauber RH
Cell Cycle; 2007 Jun; 6(12):1502-9. PubMed ID: 17582222
[TBL] [Abstract][Full Text] [Related]
13. [Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance].
Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
Bull Cancer; 2005 Mar; 92(3):219-26. PubMed ID: 15820916
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis gene signature of Survivin and its splice variant expression in breast carcinoma.
Végran F; Boidot R; Bonnetain F; Cadouot M; Chevrier S; Lizard-Nacol S
Endocr Relat Cancer; 2011 Dec; 18(6):783-92. PubMed ID: 21878572
[TBL] [Abstract][Full Text] [Related]
15. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
He XF; Wen DG; Hou JQ; He J; Cen JN
Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
[TBL] [Abstract][Full Text] [Related]
16. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
[TBL] [Abstract][Full Text] [Related]
17. Survivin is an independent prognostic marker for risk stratification of breast cancer patients.
Span PN; Sweep FC; Wiegerinck ET; Tjan-Heijnen VC; Manders P; Beex LV; de Kok JB
Clin Chem; 2004 Nov; 50(11):1986-93. PubMed ID: 15364883
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional expression of survivin and its splice variants in brain tumors in humans.
Yamada Y; Kuroiwa T; Nakagawa T; Kajimoto Y; Dohi T; Azuma H; Tsuji M; Kami K; Miyatake S
J Neurosurg; 2003 Oct; 99(4):738-45. PubMed ID: 14567610
[TBL] [Abstract][Full Text] [Related]
19. Validation of a real-time quantitative polymerase chain reaction method for the quantification of 3 survivin transcripts and evaluation in breast cancer tissues.
Pavlidou A; Kroupis C; Goutas N; Dalamaga M; Dimas K
Clin Breast Cancer; 2014 Apr; 14(2):122-31. PubMed ID: 24325949
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
Atlasi Y; Mowla SJ; Ziaee SA
Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
